Alpine Associates Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Alpine Associates Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,007,600	Closed	-$34.1M	–	71
2021 Q2	$34.1M	Buy	+1,007,600	New	+$25.7M	0.93%	28

Alpine Associates Management's CNST Position: Q3 2021 in Review

Alpine Associates Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 1,007,600 shares — an estimated $34.1M sold.

Alpine Associates Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $34.1M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Alpine Associates Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Alpine Associates Management sold 1,007,600 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $34.1M.
Alpine Associates Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Alpine Associates Management's Constellation Pharmaceuticals, Inc. position peaked at $34.1M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Alpine Associates Management's 13F filing for Q3 2021, filed 10 Nov 2021.